Nvidia takes minority stake in French health platform Doctolib for AI push
Jensen Huang announced in Paris on Tuesday, 13 October, that Nvidia will take a minority stake in the French medical booking platform. Doctolib says the capital will speed up hiring and its own AI models, and the size of the stake has not been disclosed.
The deal
Nvidia will take a minority stake in Doctolib, the French platform used to book medical appointments, Jensen Huang announced at a press point in Paris on Tuesday, 13 October. Doctolib CEO Stanislas Niox-Château told AFP that Nvidia will hold the stake without a seat on the board of directors. The number of shares Nvidia will acquire had not been disclosed at the time of the announcement. Huang said the investment is meant to "launch the revolution of artificial intelligence in Europe", and he added that he has also invested in the French AI companies Genesis IA and Pigment. According to Huang, Nvidia invested at least $8 billion in Europe last year, and the Paris stop is part of a European tour. He also said Nvidia plans to announce $2 billion in European investments in the week after 13 October, with the tour going on to London and Berlin.
What Doctolib expects
Stanislas Niox-Château said the Nvidia capital will let Doctolib hire faster and accelerate the development of its own AI models, meaning models that do not depend on large providers such as OpenAI or Anthropic. Doctolib currently builds its applications on existing language models, and it hopes the stake will give it access to Nvidia's AI experts and help with training its own models.
This investment will allow us to go much faster in the development under way of our personal health assistant for patients.
He also named assistants for caregivers, covering administrative and clinical tasks, as one of the "big priorities" for 2027-2028. Doctolib's product line already includes an AI phone assistant that lets medical practices organise appointments by telephone, along with tools for administrative and accounting work in practices. The company said all its health data remains on servers within the European Union and the United Kingdom, and that this also applies to its AI models.
Investment context
In April 2026, several international investors bought Doctolib shares worth nearly €300 million, based on a valuation of €3.6 billion. That valuation is 38% below the €5.8 billion reached in 2022. Existing Doctolib investors include Eurazeo, Bpifrance, General Atlantic and Accel.
- 2022
- 5.8 € billion
- 2026-04
- 3.6 € billion
Nvidia's market value stood at $5.433 trillion on 13 October, which makes it the world's most valuable company. Its chips are the central engine of the AI boom, and cloud companies Amazon, Google, Microsoft and Meta are putting hundreds of billions of dollars into AI data centres. Nvidia has also bought the AI platform Hugging Face in a multi-billion-dollar deal, and it often invests its chip profits in companies that are its customers.
Outlook
Nvidia has not said how many Doctolib shares it will take, and no source gives a value for the new stake. Huang's planned $2 billion in European investments is the next disclosed step, and it is planned for the week after 13 October. Niox-Château named caregiver assistants as a priority for 2027-2028, which is the timeline the company has given so far. Huang's tour continues to London and Berlin after Paris.
- Doctolib valued at €5.8 billion
- Several international investors buy nearly €300 million of shares at a €3.6 billion valuation
- Nvidia announced as minority shareholder
